Compared to those without eRVSP data, participants with a valid eRVSP were older, more likely female, leaner, less likely to be insulin-treated and more likely to have renal impairment, atrial fibrillation and heart failure (Supplementary Table S2). The gene discussed is INS; the disease is atrial fibrillation.